SurModics Analysis
| SRDXDelisted Stock | USD 42.98 0.00 0.00% |
SurModics holds a debt-to-equity ratio of 0.119. With a high degree of financial leverage come high-interest payments, which usually reduce SurModics' Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
SurModics' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. SurModics' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps SurModics Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect SurModics' stakeholders.
For most companies, including SurModics, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for SurModics, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, SurModics' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
SurModics Stock price history is provided at the adjusted basis, taking into account all of the recent filings. Sharpe Ratio = 0.2174
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | SRDX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average SurModics is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SurModics by adding it to a well-diversified portfolio.
Given that SurModics' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which SurModics is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of SurModics to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, SurModics is said to be less leveraged. If creditors hold a majority of SurModics' assets, the Company is said to be highly leveraged.
SurModics is overvalued with Real Value of 33.19 and Hype Value of 43.83. The main objective of SurModics delisted stock analysis is to determine its intrinsic value, which is an estimate of what SurModics is worth, separate from its market price. There are two main types of SurModics' stock analysis: fundamental analysis and technical analysis.
The SurModics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. SurModics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. SurModics Stock trading window is adjusted to America/New York timezone.
SurModics |
SurModics Stock Analysis Notes
About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.24. SurModics had not issued any dividends in recent years. The entity had 2:1 split on the 7th of December 2000. Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 389 people. To find out more about SurModics contact Gary Maharaj at 952 500 7000 or learn more at https://www.surmodics.com.SurModics Investment Alerts
| SurModics is not yet fully synchronised with the market data | |
| SurModics is way too risky over 90 days horizon | |
| SurModics appears to be risky and price may revert if volatility continues | |
| SurModics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 126.08 M. Net Loss for the year was (11.54 M) with profit before overhead, payroll, taxes, and interest of 92.07 M. | |
| Over 87.0% of the company shares are owned by institutional investors |
SurModics Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 614.58 M.SurModics Profitablity
The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.SurModics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SurModics insiders, such as employees or executives, is commonly permitted as long as it does not rely on SurModics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SurModics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
SurModics Outstanding Bonds
SurModics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SurModics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SurModics bonds can be classified according to their maturity, which is the date when SurModics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
SurModics Predictive Daily Indicators
SurModics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SurModics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
SurModics Debt to Cash Allocation
As SurModics follows its natural business cycle, the capital allocation decisions will not magically go away. SurModics' decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
SurModics currently holds 33.24 M in liabilities with Debt to Equity (D/E) ratio of 0.12, which may suggest the company is not taking enough advantage from borrowing. SurModics has a current ratio of 2.0, which is within standard range for the sector. Note, when we think about SurModics' use of debt, we should always consider it together with its cash and equity.SurModics Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the SurModics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of SurModics, which in turn will lower the firm's financial flexibility.SurModics Corporate Bonds Issued
About SurModics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how SurModics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SurModics shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as SurModics. By using and applying SurModics Stock analysis, traders can create a robust methodology for identifying SurModics entry and exit points for their positions.
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 389 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SurModics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in SurModics Stock
If you are still planning to invest in SurModics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SurModics' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |